×
Monday, April 6, 2026

Crescendo Bioscience, Myriad Settle Blood Test Kickback Claims - Bloomberg Law

Crescendo Bioscience Inc., Myriad Genetics Inc., and a whistleblower settled a False Claims Act suit alleging that the companies engaged in kickback schemes involving a blood test to defraud Medicare and Medicaid, the parties told a California district court.

The parties filed a stipulation of voluntary dismissal Monday with the U.S. District Court for the Northern District of California.

The terms of the settlement weren’t made available. The U.S. government consented to the dismissal. Counsel for the parties didn’t immediately respond to requests for comment.

Whistleblower STF LLC sued the companies, makers of a test that detects rheumatoid arthritis, in ...



Read Full Story: https://news.bloomberglaw.com/health-law-and-business/crescendo-bioscience-my...